The federal agency authorized the use of the Eli Lilly & Co. weight loss drug for “treatment of moderate to severe obstructive sleep apnea (OSA) in adults with obesity.” In addition to the GLP-1 ...

Zepbound led to an average weight loss of 20.2 percent compared to ... And of course, pairing the medication with a healthy diet and exercise will help deliver the best results.

A combination image shows an injection pen of Zepbound, Eli Lilly’s weight loss drug, and boxes of Wegovy, manufactured by Novo Nordisk. Reuters Eli Lilly said Wednesday that its obesity drug Zepbound ...

If you have obesity or overweight and want to lose weight, doctors may recommend trying Zepbound in combination with other lifestyle changes, such as following a well-balanced diet and exercise ...

The mega-blockbuster weight loss GLP-1 drug is now also approved to treat obstructive sleep apnea in adults with obesity, in combination with diet and exercise.

In 2024, new medicines changed how we think about healthy weight loss—but psychological factors remain just as important as ...

Attorney General Kwame Raoul is warning Illinois residents seeking GLP-1 medications – Ozempic, Wegovy, Mounjaro, Zepbound ...

The decision will largely prevent compounding pharmacies from making and selling compounded versions of the drug in the next two to three months.

The weight loss drug Zepbound has become the first prescription medication ... that the drug is used in combination with a reduced-calorie diet and increased exercise. Sleep apnea occurs when a person ...

The Food and Drug Administration approved Eli Lilly’s weight-loss drug Zepbound on Dec. 27 to treat sleep apnea, a common but ...